申请人:PASTERNAK Alexander
公开号:US20160002259A1
公开(公告)日:2016-01-07
The present invention provides compounds of Formula I
and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure, kidney disease, edema, and conditions associated with excessive salt and water retention.
本发明提供了I式化合物及其药学上可接受的盐,它们是ROMK(Kir1.1)通道的抑制剂。这些化合物可以用作利尿和/或钠利尿剂,并用于治疗和预防包括高血压、心力衰竭、肾脏疾病、水肿和与过度盐和水潴留有关的疾病等医疗条件。